Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics

被引:0
|
作者
Zhang, Heng [1 ,2 ,3 ,4 ]
Zhao, Tong [5 ]
Ding, Jiangyi [1 ,2 ,3 ,4 ]
Wang, Ziyi [1 ,2 ,3 ,4 ]
Cao, Nannan [1 ,2 ,3 ,4 ]
Zhang, Sai [1 ,2 ,3 ,4 ]
Xie, Kai [1 ,2 ,3 ,4 ]
Sun, Jiawei [1 ,2 ,3 ,4 ]
Gao, Liugang [1 ,2 ,3 ,4 ]
Li, Xiaoqin [5 ]
Ni, Xinye [1 ,2 ,3 ,4 ]
机构
[1] Nanjing Med Univ, Changzhou 2 Peoples Hosp, Dept Radiotherapy Oncol, Changzhou, Peoples R China
[2] Jiangsu Prov Engn Res Ctr Med Phys, Changzhou, Peoples R China
[3] Nanjing Med Univ, Med Phys Res Ctr, Changzhou, Peoples R China
[4] Key Lab Med Phys Changzhou, Changzhou, Peoples R China
[5] Nanjing Med Univ, Changzhou 2 Peoples Hosp, Dept Ultrasound, Changzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Radiomics; Ultrasound; Breast cancer; Peritumoral features; BREAST; CANCER; FEATURES;
D O I
10.1186/s12938-024-01315-y
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
BackgroundThis study aimed to develop and validate an ultrasound radiomics model for distinguishing invasive ductal carcinoma (IDC) from ductal carcinoma in situ (DCIS) by combining intratumoral and peritumoral features.MethodsRetrospective analysis was performed on 454 patients from Chengzhong Hospital. The patients were randomly divided in accordance with a ratio of 8:2 into a training group (363 cases) and validation group (91 cases). In addition, 175 patients from Yanghu Hospital were used as the external test group. The peritumoral ranges were set to 2, 4, 6, 8, and 10 mm. Mann-Whitney U-test, recursive feature elimination, and a least absolute shrinkage and selection operator were used to in the dimension reduction of the radiomics features and clinical knowledge, and machine learning logistic regression classifiers were utilized to construct the diagnostic model. The area under the curve (AUC) of the receiver operating characteristics, accuracy, sensitivity, and specificity were used to evaluate the model performance.ResultsBy combining peritumoral features of different ranges, the AUC of the radiomics model was improved in the validation and test groups. In the validation group, the maximum increase in AUC was 9.7% (P = 0.031, AUC = 0.803) when the peritumoral range was 8 mm. Similarly, when the peritumoral range was only 8 mm in the test group, the maximum increase in AUC was 4.9% (P = 0.005, AUC = 0.770). In this study, the best prediction performance was achieved when the peritumoral range was only 8 mm.ConclusionsThe ultrasound-based radiomics model that combined intratumoral and peritumoral features exhibits good ability to distinguish between IDC and DCIS. The selection of peritumoral range size exerts an important effect on the prediction performance of the radiomics model.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Molecular phenotypes of ductal carcinoma-in-situ and invasive ductal carcinoma: A comparative study
    Gupta, Shilpa
    Deka, Lopamudra
    Gupta, Ruchika
    Pant, Leela
    Singh, Sompal
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (01) : 43 - 46
  • [22] Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma
    Ebata, Akiko
    Suzuki, Takashi
    Takagi, Kiyoshi
    Miki, Yasuhiro
    Onodera, Yoshiaki
    Nakamura, Yasuhiro
    Fujishima, Fumiyoshi
    Ishida, Kazuyuki
    Watanabe, Mika
    Tamaki, Kentaro
    Ishida, Takanori
    Ohuchi, Noriaki
    Sasano, Hironobu
    ENDOCRINE-RELATED CANCER, 2012, 19 (04) : 485 - 496
  • [23] Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence
    Sinha, Vidya C.
    Piwnica-Worms, Helen
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2018, 23 (04) : 191 - 205
  • [24] Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma
    Liu, Bing-Tian
    Ding, Jia-Ning
    Wang, Jian-Li
    Li, Zhi-Shuang
    Ding, Yin-Lu
    Ma, Rong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (05): : 1066 - 1072
  • [25] Sonographic findings of pure ductal carcinoma in situ
    Lee, Mi Hee
    Ko, Eun Young
    Han, Boo-Kyung
    Shin, Jung Hee
    Ko, Eun Sook
    Hahn, Soo Yeon
    JOURNAL OF CLINICAL ULTRASOUND, 2013, 41 (08) : 465 - 471
  • [26] Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast
    Son, Seung Hyun
    Kim, Do-Hoon
    Hong, Chae Moon
    Kim, Choon-Young
    Jeong, Shin Young
    Lee, Sang-Woo
    Lee, Jaetae
    Ahn, Byeong-Cheol
    BMC CANCER, 2014, 14 : 585
  • [27] Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ
    Wu, Linyong
    Zhao, Yujia
    Lin, Peng
    Qin, Hui
    Liu, Yichen
    Wan, Da
    Li, Xin
    He, Yun
    Yang, Hong
    BMC MEDICAL IMAGING, 2021, 21 (01)
  • [28] Immunohistochemical Expression of E-cadherin in Sclerosing Adenosis, Ductal Carcinoma In Situ and Invasive Ductal Carcinoma of the Breast
    Facina, Gil
    Lopes-Costa, Pedro Vitor
    Dos Santos, Alesse Ribeiro
    De Vasconcelos-Valenca, Rodrigo Jose
    Pinho-Sobral, Andre Luis
    Ferreira-Filho, Celso Fires
    Alencar, Airlane Pereira
    Gebrim, Luiz Henrique
    Da Silva, Benedito Borges
    DIAGNOSTIC CYTOPATHOLOGY, 2010, 38 (04) : 235 - 238
  • [29] How Did We Get There? The Progression from Ductal Carcinoma In Situ to Invasive Ductal Carcinoma
    Dessources, Kimberly
    Martins Sebastiao, Ana Paula
    Pareja, Fresia
    Weigelt, Britta
    Reis-Filho, Jorge S.
    CURRENT BREAST CANCER REPORTS, 2019, 11 (03) : 175 - 184
  • [30] Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog
    Wahler, Joseph
    So, Jae Young
    Kim, Yeoun Chan
    Liu, Fang
    Maehr, Hubert
    Uskokovic, Milan
    Suh, Nanjoo
    CANCER PREVENTION RESEARCH, 2014, 7 (06) : 617 - 626